293 related articles for article (PubMed ID: 27975100)
21. Association of SELP Polymorphisms with Soluble P-Selectin Levels and Vascular Risk in Patients with Type 2 Diabetes Mellitus: A Case-Control Study.
Kaur R; Singh J; Kapoor R; Kaur M
Biochem Genet; 2019 Feb; 57(1):73-97. PubMed ID: 30047017
[TBL] [Abstract][Full Text] [Related]
22. Circulating miR-103 family as potential biomarkers for type 2 diabetes through targeting CAV-1 and SFRP4.
Luo M; Xu C; Luo Y; Wang G; Wu J; Wan Q
Acta Diabetol; 2020 Mar; 57(3):309-322. PubMed ID: 31583475
[TBL] [Abstract][Full Text] [Related]
23. The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy.
Shi R; Zhou X; Ji WJ; Zhang YY; Ma YQ; Zhang JQ; Li YM
Biomed Res Int; 2015; 2015():981841. PubMed ID: 26221610
[TBL] [Abstract][Full Text] [Related]
24. Hyperglycemia enhances arsenic-induced platelet and megakaryocyte activation.
Newman JD; Echagarruga CT; Ogando YM; Montenont E; Chen Y; Fisher EA; Berger JS
J Transl Med; 2017 Mar; 15(1):55. PubMed ID: 28264687
[TBL] [Abstract][Full Text] [Related]
25. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes.
Osman A; Fälker K
Platelets; 2011; 22(6):433-41. PubMed ID: 21438667
[TBL] [Abstract][Full Text] [Related]
26. Detection of platelet microRNA expression in patients with diabetes mellitus with or without ischemic stroke.
Duan X; Zhan Q; Song B; Zeng S; Zhou J; Long Y; Lu J; Li Z; Yuan M; Chen X; Yang Q; Xia J
J Diabetes Complications; 2014; 28(5):705-10. PubMed ID: 24908639
[TBL] [Abstract][Full Text] [Related]
27. MiR-181a Reduces Platelet Activation
Dahiya N; Atreya CD
Microrna; 2020; 9(3):240-246. PubMed ID: 31738148
[TBL] [Abstract][Full Text] [Related]
28. Impairment of Wound Healing in Patients With Type 2 Diabetes Mellitus Influences Circulating MicroRNA Patterns via Inflammatory Cytokines.
Dangwal S; Stratmann B; Bang C; Lorenzen JM; Kumarswamy R; Fiedler J; Falk CS; Scholz CJ; Thum T; Tschoepe D
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1480-8. PubMed ID: 25814674
[TBL] [Abstract][Full Text] [Related]
29. Hypertension Associated With Hyperlipidemia Induced Different MicroRNA Expression Profiles in Plasma, Platelets, and Platelet-Derived Microvesicles; Effects of Endothelial Progenitor Cell Therapy.
Alexandru N; Constantin A; Nemecz M; Comariţa IK; Vîlcu A; Procopciuc A; Tanko G; Georgescu A
Front Med (Lausanne); 2019; 6():280. PubMed ID: 31850358
[No Abstract] [Full Text] [Related]
30. Impact of preeclampsia on megakaryocytopoesis and platelet homeostasis of preterm infants.
Yang J; Zhang H; Niu J; Mu X; Zhang X; Liu Y; Wang J; Chen Y
Platelets; 2016; 27(2):123-7. PubMed ID: 26083681
[TBL] [Abstract][Full Text] [Related]
31. Expression of dicer and its related miRNAs in the progression of prostate cancer.
Bian X; Shen Y; Zhang G; Gu C; Cai Y; Wang C; Zhu Y; Zhu Y; Zhang H; Dai B; Ye D
PLoS One; 2015; 10(3):e0120159. PubMed ID: 25768283
[TBL] [Abstract][Full Text] [Related]
32. Platelet activity and hypercoagulation in type 2 diabetes.
Pretorius L; Thomson GJA; Adams RCM; Nell TA; Laubscher WA; Pretorius E
Cardiovasc Diabetol; 2018 Nov; 17(1):141. PubMed ID: 30388964
[TBL] [Abstract][Full Text] [Related]
33. Association of MicroRNAs and YRNAs With Platelet Function.
Kaudewitz D; Skroblin P; Bender LH; Barwari T; Willeit P; Pechlaner R; Sunderland NP; Willeit K; Morton AC; Armstrong PC; Chan MV; Lu R; Yin X; Gracio F; Dudek K; Langley SR; Zampetaki A; de Rinaldis E; Ye S; Warner TD; Saxena A; Kiechl S; Storey RF; Mayr M
Circ Res; 2016 Feb; 118(3):420-432. PubMed ID: 26646931
[TBL] [Abstract][Full Text] [Related]
34. Platelet microRNA expression and association with platelet maturity and function in patients with essential thrombocythemia.
Tran JQD; Pedersen OH; Larsen ML; Grove EL; Kristensen SD; Hvas AM; Nissen PH
Platelets; 2020; 31(3):365-372. PubMed ID: 31240987
[TBL] [Abstract][Full Text] [Related]
35. Elevated platelet activation in patients with chronic urticaria: a comparison between aspirin-intolerant and aspirin-tolerant groups.
Palikhe S; Palikhe NS; Kim SH; Yoo HS; Shin YS; Park HS
Ann Allergy Asthma Immunol; 2014 Sep; 113(3):276-81. PubMed ID: 25037610
[TBL] [Abstract][Full Text] [Related]
36. Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effects.
Gwozdz AM; Leung R; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
Thromb Haemost; 2010 Jun; 103(6):1218-27. PubMed ID: 20352156
[TBL] [Abstract][Full Text] [Related]
37. High glucose levels enhance platelet activation: involvement of multiple mechanisms.
Sudic D; Razmara M; Forslund M; Ji Q; Hjemdahl P; Li N
Br J Haematol; 2006 May; 133(3):315-22. PubMed ID: 16643434
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
39. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study.
Seyhan AA; Nunez Lopez YO; Xie H; Yi F; Mathews C; Pasarica M; Pratley RE
Sci Rep; 2016 Aug; 6():31479. PubMed ID: 27558530
[TBL] [Abstract][Full Text] [Related]
40. Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.
Higuchi C; Nakatsuka A; Eguchi J; Teshigawara S; Kanzaki M; Katayama A; Yamaguchi S; Takahashi N; Murakami K; Ogawa D; Sasaki S; Makino H; Wada J
Metabolism; 2015 Apr; 64(4):489-97. PubMed ID: 25726255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
